Radioprotection of murine gastrointestinal epithelium by interleukin-1α involves down-regulation of the apoptotic response

Anticancer Research

Volumn 28, Issue 6 A, 2008, Pages 3601-3607

  Johnke, Roberta M ^a   Smith, Elizabeth S ^a   Cariveau, Mickael J ^a   Evans, Mark J ^a   Kilburn, Jeremy M ^a   Bakken, Nicholas T G ^a   Nangami, Gladys N ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Apoptosis; Gastrointestinal epithelium; Interleukin 1; Radioprotection

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; INTERLEUKIN 1ALPHA; PARAFFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GOBLET CELL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; JEJUNUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION ATTENUATION; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; STOMACH EPITHELIUM; STOMACH PROTECTION; TISSUE FIXATION;

ANIMALS; APOPTOSIS; CASPASES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; INTERLEUKIN-1ALPHA; ISOENZYMES; JEJUNUM; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS;

EID: 58149174377     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hauer-Jensen M, Wang J and Denham JW: Bowel injury: current and evolving management strategies. Semin Radiat Oncol 13: 357-371, 2003.
2. Neta R: Modulation with cytokines of radiation damage: suggested mechanisms of action. Environ Health Perspect 105(Suppl 6): 1463-1465, 1997.
3. Wu S-G and Miyamoto T: Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1α. Radiat Res 123: 112-115, 1990.
4. Hancock SL, Chung RT, Cox RS and Kallman RF: Interleukin-1 beta initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiation. Cancer Res 51: 2280-2285, 1991.
5. Potten CS: Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res 161: 123-136, 2004.
6. Eastgate J, Moreb J, Nick HS, Suzuki K, Taniguchi N and Zucali JR: A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood 81: 39-646, 1993.
7. Johnke RM, Abernathy RS, Kovacs CJ, Evans MJ, Biggs LE, Daly BM and Loven DP: Antioxidant enzyme activity in murine hematopoietic bone marrow following treatment with interleukin-1 alpha: Influence of tumor. Anticancer Res 17(3C): 2169-2174, 1997.
8. Schwartz GN, Neta R, Vigneulle RM, Patchen ML and MacVittie TJ: Recovery of hematopoietic colony-forming cells in irradiated mice pretreated with interleukin-1 (IL-1). Exp Hematol 16: 752-767, 1988.
9. Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP and Bours V: Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates. Eur J Biochem 242: 544-549, 1996.
10. Simonart T and Van Vooren JP: Interleukin-1 beta increases the BCL-2/BAX ratio in Kaposi's sarcoma cells. Cytokine 19: 259-266, 2002.
11. Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N and Van Waes C: IL (interleukin)-1alpha promotes nuclear factor-kappa B and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7: 1812-1820, 2001.
12. Daniel PT: Dissecting the pathways to death. Leukemia 14: 2035-2044, 2004.
13. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M,Boulton RA, Thim L and Hanby AM: Human spasmolytic polypeptides a cytoprotective agent that stimulates cell migration. Gastroenterology 108: 108-116, 1995.
14. Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R and Hanby AM: Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 93: 2137-2142, 1996.
15. Thim L: A new family of growth factor-like peptides. "Trefoil" disulphide loop structures as a common feature in breast cancer-associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 250: 85-90, 1989.
16. Sands BE and Podolsky DK: The trefoil peptide family. Annu Rev Physiol 58: 253-273, 1996.
17. Booth C and Potten CS: Protection against mucosal injury by growth factors and cytokines. J Nat Cancer Inst 29: 16-20, 2001.
18. Bossenmeyer-Pourié C, Kannan R, Ribieras S, Wendung C, Stoll I, Thim L, Tomasetto C and Rio MC: The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157: 761-70, 2002.
19. Kinoshita K, Taupin DR, Itoh H and Podolsky DK: Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20: 4680-4690, 2000.
20. Wright N: Trefoil peptides. Gut 44: 890-895, 1999.
21. Meyer zum Büschenfelde D, Tauber R and Huber O: TFF3-peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression. Peptides 27: 3383-3390, 2006.
22. Hoffmann W: Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 62: 2932-2938, 2005.